Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial DNA polymerase III (Pol III) is the primary enzyme complex responsible for the replication of the bacterial chromosome [7, 13]. It is a multi-subunit holoenzyme that exhibits high processivity and fidelity, essential for rapid and accurate genome duplication during cell division [11, 17]. The enzyme consists of a catalytic core (alpha, epsilon, and theta subunits), a sliding clamp (beta subunit) for processivity, and a clamp loader complex [7, 8]. In many bacteria, Pol III exists in two main forms: PolC, predominant in low-GC Gram-positive bacteria, and DnaE, found in Gram-negative bacteria and Mycobacteria [4, 15]. Because Pol III is structurally distinct from eukaryotic DNA polymerases, belonging to the C-family rather than the B-family, it serves as an attractive target for the development of narrow-spectrum and broad-spectrum antibiotics [14, 19]. Inhibitors such as ibezapolstat target the PolC subunit by mimicking natural nucleotides and sequestering the enzyme into inactive complexes, effectively halting bacterial growth [18, 21]. This target is particularly relevant for treating infections like Clostridioides difficile and multidrug-resistant tuberculosis [22, 26]. Recent clinical developments have focused on narrow-spectrum inhibitors that minimize damage to the host microbiome [18, 22].
Inhibition of DNA synthesis by competing with natural nucleotides (e.g., dGTP) or sequestering the enzyme into inactive ternary complexes with DNA; some inhibitors also disrupt the interaction between the polymerase and the sliding clamp (beta-clamp/DnaN).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial DNA polymerase III (Pol III) (Pol III).